Ecoworks Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 12-12-2024
- Paid Up Capital ₹ 1.50 M
as on 12-12-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 2.50 M
as on 12-12-2024
- Revenue -4.86%
(FY 2018)
- Profit -87.11%
(FY 2018)
- Ebitda -69.84%
(FY 2018)
- Net Worth 3.26%
(FY 2018)
- Total Assets -6.83%
(FY 2018)
About Ecoworks Biotech
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹2.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maninee Karnik and Valentine Pereira serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC233254
- Company No.
233254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ecoworks Biotech Private Limited offer?
Ecoworks Biotech Private Limited offers a wide range of products and services, including Toilet Cleaners, Drain Cleaners, Cleaning Chemicals, Stain Removers, Cleaning Liquids & Wipes, Housekeeping and Cleaning Services, Commercial Cleaning Services, Surface Cleaner, Wash Basins, Sanitaryware & Fittings, Kitchen Sinks.
Who are the key members and board of directors at Ecoworks Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maninee Karnik  | Director | 11-Jul-2012 | Current |
Valentine Pereira  | Director | 11-Jul-2012 | Current |
Financial Performance and Corporate Structure Insights of Ecoworks Biotech.
Ecoworks Biotech Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 4.86% decrease. The company also saw a substantial fall in profitability, with a 87.11% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ecoworks Biotech?
In 2019, Ecoworks Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Nov 2016 | ₹2.50 M | Satisfied |
How Many Employees Work at Ecoworks Biotech?
Unlock and access historical data on people associated with Ecoworks Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ecoworks Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ecoworks Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
